International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum computing’s promise in medicine. While Moderna isn’t looking to replace ...

Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

A vial and syringe are seen in front of a displayed Moderna logo in this illustration taken Jan 11, 2021. [Photo/Agencies] SHANGHAI - American biotech company Moderna on Monday commenced construction ...

Moderna said on Monday its experimental influenza vaccine showed superior efficacy compared with a licensed standard-dose seasonal flu shot in adults aged 50 years and older in a late-stage study.

When the PMCPA put the latest complaint to Moderna, the biotech “strongly” disagreed with the allegations, reiterating its claim that it only learned about the message in 2024.

But Moderna is on track to be successful over the long term, even as early as five years from now. That makes it a great buy for biotech investors today. Should you invest $1,000 in Moderna right now?

The weekend's resignation announcement of FDA official Peter Marks hit biotech stocks on Monday and sent Wall Street into a frenzy of concern over the future of biopharma approvals in the near term.

A vial and syringe are seen in front of a displayed Moderna logo in this illustration taken Jan 11, 2021. [Photo/Agencies] SHANGHAI - US biotechnology company Moderna inked a strategic cooperation ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Moderna, Inc.

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where Moderna, Inc. (NASDAQ:MRNA) stands against ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu. The biotech firm's mRNA-1018 candidate posted positive ...